Role of mechanical hysteroscopic tissue removal system in post-molar gestational trophoblastic neoplasia management: case report and literature review

Complete hydatidiform moles are precancerous gestational trophoblastic diseases, with 15%-20% progressing to post-molar neoplasia. The gold standard treatment of low-risk neoplasia is single-agent chemotherapy. A second curettage is an alternative to avoid chemotherapy; hysteroscopic resection is not described in the guidelines. We report a case of post-molar neoplasia treated using a mechanical hysteroscopic tissue removal system (TruClear°) and review the limited literature on the subject. A patient was diagnosed with low-risk post-molar neoplasia in our department. Ultrasound evaluation revealed uterine trophoblastic retention, which was managed with mechanical hysteroscopic resection. In conclusion, hysteroscopic resection could be a potential alternative to second curettage in highly selected cases of low-risk post-molar neoplasia.

Authors

Institutions

Publication Details

Journal
Journal of Surgical Case Reports
Published
2025-03-29
DOI
https://doi.org/10.1093/jscr/rjaf190
Primary Topic
Gestational Trophoblastic Disease Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of mechanical hysteroscopic tissue removal system in post-molar gestational trophoblastic neoplasia management: case report and literature review

Frédéric Kridelka, Frédéric Goffin, Patricia Nervo, Sophie Schoenen et al.
1 links
Journal of Surgical Case Reports
Gestational Trophoblastic Disease Studies
article

Role of mechanical hysteroscopic tissue removal system in post-molar gestational trophoblastic neoplasia management: case report and literature review

Frédéric Kridelka, Frédéric Goffin, Patricia Nervo, Sophie Schoenen, Katty Delbecque, Florence Hanocq
article en

Abstract

Complete hydatidiform moles are precancerous gestational trophoblastic diseases, with 15%-20% progressing to post-molar neoplasia. The gold standard treatment of low-risk neoplasia is single-agent chemotherapy. A second curettage is an alternative to avoid chemotherapy; hysteroscopic resection is not described in the guidelines. We report a case of post-molar neoplasia treated using a mechanical hysteroscopic tissue removal system (TruClear°) and review the limited literature on the subject. A patient was diagnosed with low-risk post-molar neoplasia in our department. Ultrasound evaluation revealed uterine trophoblastic retention, which was managed with mechanical hysteroscopic resection. In conclusion, hysteroscopic resection could be a potential alternative to second curettage in highly selected cases of low-risk post-molar neoplasia.

Journal of Surgical Case ReportsVol. 2025(4)
University of Liège (BE)
Good health and well-being
Openalex Percentile: Top 90%
Gestational Trophoblastic Disease Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Role of mechanical hysteroscopic tissue removal system in post-molar gestational trophoblastic neoplasia management: case report and literature review — Frédéric Kridelka, Frédéric Goffin, et al. · Journal of Surgical Case Reports (2025) | TGRS Research Map | TGRS